Feng Y. Yue

St. Michael's Hospital, Unity Health
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

5' leader defects drive persistent HIV-1 viremia on long-term ART.

5' leader defects drive persistent HIV-1 viremia on long-term ART.

Journal: Nature communications

Published: October 21, 2025

mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.

mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.

Journal: Journal of virology

Published: January 31, 2025

Corrigendum to "Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine" [Clinical Immunology 237 (2022) 108963].

Corrigendum to "Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine" [Clinical Immunology 237 (2022) 108963].

Journal: Clinical immunology (Orlando, Fla.)

Published: May 05, 2023

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.

Journal: Science advances

Published: January 19, 2022

Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine.

Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine.

Journal: Clinical immunology (Orlando, Fla.)

Published: December 30, 2021

Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.

Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 21, 2021

Elevated glycolysis imparts functional ability to CD8+ T cells in HIV infection.

Elevated glycolysis imparts functional ability to CD8+ T cells in HIV infection.

Journal: Life science alliance

Published: March 30, 2021

A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies.

A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies.

Journal: Nature communications

Published: November 18, 2020

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.

Journal: Science immunology

Published: August 28, 2020

Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice.

Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice.

Journal: Vaccine

Published: July 26, 2019

HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.

HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.

Journal: Journal of virology

Published: October 15, 2018

Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.

Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.

Journal: Journal of virology

Published: April 14, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026